Choroidal Caverns in Stargardt Disease

Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):25. doi: 10.1167/iovs.63.2.25.

Abstract

Purpose: To report choroidal caverns in patients affected by recessive Stargardt disease (STGD1) and to investigate its clinical features.

Methods: Retrospective analysis of STGD1 patients recruited at the Regional Reference Center for Hereditary Retinal Degenerations at the Eye Clinic in Florence from 2012 to 2017. Patients included in the study underwent a complete ophthalmic examination including best-corrected visual acuity, color fundus photography, fundus autofluorescence, optical coherence tomography (OCT) and OCT angiography.

Results: Eighty-six patients (172 eyes) were included in the study. Twenty-three eyes (13.3%) of 21 patients presented choroidal caverns. The total number of detected choroidal caverns was 63. Choroidal caverns were only present in patients with stage III and IV STGD. Interestingly, patients with choroidal caverns presented larger macular atrophy (20.53 ± 16.9 mm2 vs. 18.11 ± 20.39 mm2), worse visual acuity (1.03 ± 0.29 vs. 0.83 ± 0.26), and a thinner choroidal thickness (245.9 ± 88.7 vs. 266.0 ± 110.5 µm).

Conclusions: Choroidal caverns are present only in the advanced stage of STGD1, and a possible degenerative origin of the finding has been hypothesized.

MeSH terms

  • ATP-Binding Cassette Transporters / genetics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Choroid Diseases / diagnostic imaging
  • Choroid Diseases / etiology*
  • Choroid Diseases / physiopathology
  • Computed Tomography Angiography
  • Female
  • Humans
  • Male
  • Middle Aged
  • Optical Imaging
  • Retrospective Studies
  • Stargardt Disease / complications*
  • Stargardt Disease / genetics
  • Stargardt Disease / physiopathology
  • Tomography, Optical Coherence
  • Visual Acuity / physiology
  • Young Adult

Substances

  • ABCA4 protein, human
  • ATP-Binding Cassette Transporters